BCL2 and neoplasm: IC50= 8.62 μM; Dose-dependent DNA fragmentation and increase Bax/Bcl-2 expressions by Segetoside I (0.82, 8.2, 82 μM); Dose-dependent inhibition of tumor growth with segetoside I